Latest Company News
- Novartis To Buy Neuroscience Therapy Biz For Up To $770M Law 360 Mergers and Acquisitions
- Novartis announces FDA approval of Xolair (omalizumab) for adults with nasal polyps The Medford Central Record - News
- Novartis announces share buyback plan worth $2.5B Biotechnology Industry Organization BIO SmartBrief
- Enel Green Power and Novartis enter into renewable energy agreement Energy Global
- Novartis announces collaboration with Molecular Partners to develop two DARPin therapies designed for potential use against COVID-19
- Novartis Unit Seeks 11.3M Damages Over Invalidated Patent Law 360 Intellectual Property
- Amgen prevails in Enbrel patent dispute with Novartis Seeking Alpha Latest
- $2.1B Novartis bond sale linked to sustainability push American Association of Blood Banks AABB SmartBrief
- Novartis CEO says COVID-19 makes valuing takeover targets tougher EIN News
- Novartis up 2% on Gilenya patent win Seeking Alpha Latest
Get access to financial news alerts, bankruptcy, court filings, and other credit related insights by joining the Cortera Credit Community - Completely free!